Summit Rewind 2024

Publication Highlights

Champion Mindset: Overcoming Adversity and Tenacity During Challenging Times National Champion/Olympic high jumper Chaunté Lowe provides insight on succeeding while overcoming adversity. Page 4

Advances in Breast Cancer Treatment and Current Updates An overview of promising new developments, including CDK4/6 inhibitors and monoclonal antibodies. Page 4

Medicare Prescription Payment Plan Overview How recent changes in Medicare will provide significant relief for beneficiaries dealing with high prescription costs. Page 5

NCODA PQI: Practical Strategies to Transform Oncology Care Panelists discuss how NCODA’s Positive Quality Intervention (PQI) and PQI In Action resources can benefit your practice. Page 5

Staying Up-To-Date with Upper Gastrointestinal Malignancies A look at the latest regimens, focusing on advances in biomarker-directed therapy and supportive care strategies. Page 7

A Review of Prostate Cancer & Recent Updates in the Treatment of Metastatic Prostate Cancer Discussion of current treatment options, including androgen deprivation, hormonal and targeted therapies. Page 7

Preparing for a Career in Oncology John Bossaer, an oncology pharmacist and professor, reviews the skills needed to excel in oncology pharmacy. Page 8

Addressing Cancer Disparities and Social Determinants of Health in Unique Rural Populations How students are helping to relieve one of the highest cancer burdens in the U.S. Page 8

A Combination Treatment for Patients with Advanced Renal Cell Carcinoma An in-depth review of the CheckMate 9ER trial, which evaluated cabozantinib in combination with nivolumab. Page 9

NCODA’s Nonprofit Partner Update and Donor Recipient Story: NMDP How a stem-cell transplant donation gave a caregiver’s husband the gift of life. Page 9

VONJO®’s Voyage: Navigating Thrombocytopenia in Myelofibrosis Pacritinib, the first JAK1-sparing inhibitor, has proven to be an effective therapeutic option in treating low platelet issues. Page 10

Precision Medicine in Lung Cancer: The Role of the Medically Integrated Team Advancements in Stage III lung cancer treatment, including immunotherapy, targeted therapy and next-generation sequencing. Page 10

New Options for Patients: Latest Oncology Trends A review of the rise and decline in sales of targeted, hormonal, cytotoxic and radiopharmaceutical drugs. Page 11

Exploring Bispecifics and CAR-T Therapies Comparing and contrasting the efficacy and challenges of each option in treating B-cell lymphoid malignancies. Page 11